AcelRx Pharmaceuticals
ACRX
#10816
Rank
โ‚ฌ13.28 M
Marketcap
0,78ย โ‚ฌ
Share price
7.50%
Change (1 day)
48.18%
Change (1 year)

EPS for AcelRx Pharmaceuticals (ACRX)

EPS in 2023 (TTM): -2,06ย โ‚ฌ

According to AcelRx Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -2,03ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of 4,97ย โ‚ฌ an increase over its 2021 EPS that were of -5,28ย โ‚ฌ.

EPS history for AcelRx Pharmaceuticals from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-2,06ย โ‚ฌ-141.58%
20224,97ย โ‚ฌ-193.97%
2021-5,28ย โ‚ฌ-39.58%
2020-8,75ย โ‚ฌ-28.36%
2019-12,21ย โ‚ฌ-18.29%
2018-14,94ย โ‚ฌ
2013-12,03ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Cara Therapeutics
CARA
-19,14ย โ‚ฌ 841.70%๐Ÿ‡บ๐Ÿ‡ธ USA